Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Transfusion and Apheresis ScienceReferences
Belák M, Widder RA, Brunner R, Borberg H, Haupt WF. Immunoadsorption with protein A sepharose or silica (letter). Lancet 1994;343:792–793
Blankenhorn DH, Myers HI. Radiographic determination of Achilles tendon xanthoma size. Metabolism 1969;18:882–886
Borberg H, Stoffel W, Oette K. The development of specific plasmaimmunoadsorption. Plasma Ther Transfus Technol 1983;4(4):459–466
Borberg H. The development of an automated therapeutic immunoadsorption system using the LDL-apheresis model. Eur J Clin Invest 1983;13:A39
Borberg H, Gaczkowski A, Hombach V, Oette K, Stoffel W. Treatment of familial hypercholesterolaemia by means of specific immunoadsorption. J Clin Apheresis 1988;4:59–65
Borberg H, Oette K. Experience with and conclusions from three trials on LDL-Apheresis. In: Agishi T. et al., editors. Therapeutic plasmapheresis (XII). VSP BV, Utrecht, 1993, p. 13–20
Borberg H, Oette K. Outlooks in LDL-apheresis. In: Koenig W, Hombach V, Bond MG, Kramsch DM, editors. Progression and regression of atherosclerosis. Blackwell Wissenschaft, Wien, 1995, p. 306–318
Borberg H. Extracorporeal elimination therapy of autoimmune diseases. In: Yamamoto A, Gurland HJ, editors. Current advances in haemapheresis. Churchill Livinstone, 1995, p. 83–93
De Gennes JL, Toutaine R, Maunand B, Truffert J, Laudat P. Forme homozygotes cutaneo-tendineuses de xanthomatose hypercholesterolèmique dans une observation familiale exemplaire. Essai de plasmaphèrése a titre de traitement heroique. Bull. Mem. Soc. Hop. Paris 1967;118:1377–13402
Freudenhammer, Ch. Untersuchungen zur Biokompatibilität der LDL-Apherese. Aktivierung von Monozyten und neutrophilen Granulozyten. Thesis, University of Köln, 1997
Gupta S, Leatham EW. The relation between Clamydia pneumoniae and atherosclerosis. Brit Med J 1997;77:7–8
Gdawitz, A, Nagel R, Degenhardt R, Borberg H, Schmid-Schönbein H. High resolution constant shear platelet aggregometry: effect of hyperlipidaemia and hae mapheretic treatment of hypercholesterolaemia Abstract, 14.Jahrestagg. Dtsch.Gesellsch. Klin. Mikrozirkulat. Haemorheol., Berlin, 1995
Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation 1994;89:1530–1538
Hombach V, Borberg H, Gaczkowski A, Oette K, Stoffel W. Regression der Koronarsklerose bei familiärer Hyperchoelsterinämie Typ IIa durch spezifische LDL-Apherese. Dtsch Med Wschr 1986;45:1709–1715
Hummelsheim T, Borberg H, Brunner R, Oette K. Acute changes of haemorheological parameters by LDL-Apheresis: specific immunoadsorption versus cascade filtration. Infusionsther Transfusionsmed 1994;22 Suppl 1:42–44
Jimenez-Klingberg C, Borberg H. Comparison of protein A and tryptophan conjugated polyvinyl-alcohol gel columns with an anti-human immunoglobulin adsorber. In: Yamamoto A, Gurland HJ, editors. Current advances in haemapheresis. Churchill Livinstone, 1995, p. 83–93
Jimenez-Klingberg C, Borberg H, Belak M, Späth P. Selektive Adsorption von Kryoglobulinen aus dem Plasma von drei Patienten mit gemischterTyp II Kryoglobulinämie. Beitr Infusionsther Transfusionsmed 1994;32:370–373
Kadar JG, Späth PJ, Gaczkowski A, Oette K, Stoffel W, Borberg H. Biocompatibility studies on a clinically well tolerated extracorporeal system. Plasma Ther Transfus Technol 1988;8:307–318
Kikkawa T, Yokoyama S, Hayashi R, Yamamoto A, Santini M, Kishino B. Specificity of various plasmapheresis techniques for the treatment of hypercholesterolaemia. In: Shiokawa Y, Inoue N, editors. Current practice in therapeutic plasmapheresis. Excerpta Medica, Amsterdam, 1985, p. 144–151
Koga N, Nomura G, Yamagata Y, Takada S, Nishimura T, Sanada A, Kanaya S, Fujino T. Double filtration plasmapheresis of two cases of homozygous familial hypercholesterolemia. In: Oda T, editors. Therapeutic plasmapheesis III. Schattauer, Stuttgart, 1983, p. 109–112
Koga N, Sato T, Kurashige Y, Nagano T, Hashizume K, Iwamoto H. Longterm effects of LDL-liposorption on coronary and carotid athersosclerosis in familial hypercholesterolaemia opatients. In: Yamamoto A, editor. Therapeutic plasmapheresis XVI. Jpn J Apheresis 1997, p. 63–68
Kroon AA, Aengevaeren WRM, van der Werf T, Uijen GJH, Reiber HC, Bruschke AVG, Stahlenhof AFH. Liposorption atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996;93:1826–1835
Leung WH. Beneficial effect of cholesterol lowering therapy on coronary endothelium-dependent rexation in hypercholesterolaemic patients. Lancet 1993;341:1496–1500
Levine GN, Keany JF, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995;332:512–521
Minakata T, Fukasawa A, Fujiwara S. Treatment of familial hypercholesterolemia using double filtration leukapheresis. In: Oda T, editor. Therapeutic plasmapheesis III. Schattauer, Stuttgart, 1983, p. 109–112
Oette K, Borberg H. Variables in regression of atherosclerosis in familial hypercholesterolaemic patients under longterm LDL-apheresis. Plasma Ther Transfus Technol 1988;9:17–23
Parusel M. Untersuchungen zur Biokompatibilität der LDL-Apherese. Interaktionen zwischen der Anti-Apolioprotein-B IgG-Sepharose 4B Cl. dem Komplementsystem und den Blutzellen. Thesis, University of Köln, 1994
Sacks FM, Rouleau JL, Moye LA, Pfeffer MA, Warnica JW, Arnold MO, Nash DT, Brown LE, Sestier F, Rutherford J, Davis BR, Hawkins CM, Braunwald E. Baseline characteristics in the cholesterol and recurrent events (CARE). Trial of secondary prevention in patients with average serum cholesterol levels. Am J Cardiol 1995;75:621–623
Saikku P, Mattila K, Nieminen MS, Hutten JK, Leinonen M, Ekman MR, Makela PH, Valtona V. Serological evidence of an association of a novel Clamydia, TWAR, with chronic heart disease and acute myocardial infarction. Lancet 1988;ii:983–985
Scandinavian Simvastation survival study (4S). Lancet 1994;344:1383–1389
Schuff-Werner P. Untersuchungen zur hämorheologischen Wirksamkeit der LDL-Apherese. Habilitationsschrift, Universität Göttingen, 1989
Schuff-Werner P, Gohlke H, Bartmann U, Baggio G, Corti MC, Dinsenbacher A, Eisenhauer T, Grützmacher P, Keller C, Kettner U, Kleophas W, Köster W, Olbricht CJ, Richter WO, Seidel D. The Help-apheresis multicenter study. Eur J Clin Invest 1994;24:724–732
Shepherd J, Cobbe SM, Ford I, Isles CH, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention (WESCOP) Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995;333:1301–1307
Stoffel W, Demant T. Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma. Proc Natl Acad Sci USA 1981;78:611–615
Stoffel W, Borberg H, Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet II 1981:1005–1007
Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T, Yasugi T, Yamamoto A. Regression of coronary atherosclerosis by combined liposorption and lipid lowering drug therapy in patients with familial hypercholesterolaemia. A multicenter study. Atherosclerosis 1992;95:1–13
Thompson GR, Myant NB, Kilpatrick D, Oakley CM, Raphael MJ, Steiner RE. Assessment of long-term plasma exchange for familial hypercholesteroaemia. Brit Heart J 1980;43:680–688
Thompson GR, Miller P, Breslow JL. Improved survival of patients with homozygous familial hypercholesteroaemia treated by plasma exchange. Brit Med J 1985;291:1671–1673
Thompson GR, Maher VMG, Mattews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ, de Feyter P, Henderson A. Familial hypercholesterolaemia regression study. Lancet 1995;345:811–816
Waidner T, Franzen D, Voelker W, Ritter M, Borberg H, Hombach V, Höpp HW, for the LDL-Apheresis Study Group. The effect of LDL-apheresis on progression of coronary artery disease in patients with familial hypercholesterolaemia. Results of a multicenter LDL-apheresis study. Clin Invest 1994;72:858–863
